NCT07085767
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07085767
Title Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02)
Acronym OPERA-02
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Olema Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Ames Iowa 50010 United States Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Scarborough Maine 04074 United States Details
Clinical Trial Site RECRUITING Kansas City Missouri 64132 United States Details
Clinical Trial Site RECRUITING Santa Fe New Mexico 87505 United States Details
Clinical Trial Site RECRUITING Sayre Pennsylvania 18840 United States Details
Clinical Trial Site NOT_YET_RECRUITING Tennessee City Tennessee 37203 United States Details
Clinical Trial Site NOT_YET_RECRUITING Salt Lake City Utah 84106 United States Details
Clinical Trial Site RECRUITING Sydney New South Wales 2109 Australia Details
Clinical Trial Site RECRUITING Waratah New South Wales 2298 Australia Details
Clinical Trial Site RECRUITING Adelaide South Australia 5000 Australia Details
Clinical Trial Site RECRUITING Clayton Victoria 3168 Australia Details
Clinical Trial Site RECRUITING Geelong Victoria 3220 Australia Details
Clinical Trial Site RECRUITING Nedlands Western Australia 6009 Australia Details
Clinical Trial Site RECRUITING Hong Kong Kowloon 999077 Hong Kong Details
Clinical Trial Site RECRUITING Hong Kong Pok Fu Lam 999077 Hong Kong Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Dusit Bangkok 10300 Thailand Details
Clinical Trial Site ACTIVE_NOT_RECRUITING Ban Phaeo Changwat Samut Sakhon 74120 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field